Scientists probe why elderly hearts resist common blood thinner
NCT ID NCT04990596
Summary
This study aimed to understand why the blood-thinning drug clopidogrel is less effective for preventing heart attacks and strokes in many people over 70. Researchers observed 37 hospitalized patients aged 50-100 who were already taking the drug. They measured drug levels in the blood and tested how well the drug was working on platelets to see how age affects the body's processing of the medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG RESISTANCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de RENNES
Rennes, France
-
Hôpital Charles Foix
Paris, France
-
Hôpital Européen Georges Pompidou,
Paris, France
-
Hôpital Lariboisière
Paris, France
Conditions
Explore the condition pages connected to this study.